Literature DB >> 12917135

Peripheral third cranial nerve enhancement in multiple sclerosis.

M Tariq Bhatti1, Ilona M Schmalfuss, Lorna S Williams, Ronald G Quisling.   

Abstract

Cranial nerve III dysfunction in multiple sclerosis (MS) is uncommon. Seven cases of isolated cranial nerve III paresis associated with MS have been reported in the English-language literature. MR imaging was obtained in five cases demonstrating lesions within the midbrain. We present the detailed clinical and MR imaging findings of a young woman with MS and an isolated, painful pupil involving complete left cranial nerve III palsy. Initial MR imaging showed isolated enhancement of the cisternal portion of the cranial nerve III, suggesting that peripheral nervous system involvement may develop as part of the disease process in some patients with MS.

Entities:  

Mesh:

Year:  2003        PMID: 12917135      PMCID: PMC7973702     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  32 in total

1.  Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study.

Authors:  I E Ormerod; H M Waddy; A G Kermode; N M Murray; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-09       Impact factor: 10.154

2.  Cranial nerve enhancement on three-dimensional MRI in Miller Fisher syndrome.

Authors:  U Nagaoka; T Kato; K Kurita; S Arawaka; T Hosoya; N Yuki; Y Shikama; K Yamaguchi; H Sasaki
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

3.  Combined central and peripheral myelinopathy.

Authors:  M Rubin; G Karpati; S Carpenter
Journal:  Neurology       Date:  1987-08       Impact factor: 9.910

4.  Isolated cranial nerve palsies in multiple sclerosis.

Authors:  F Thömke; E Lensch; K Ringel; H C Hopf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

5.  Abducens nerve enhancement demonstrated by multiplanar reconstruction of contrast-enhanced three-dimensional MRI.

Authors:  T Hosoya; M Adachi; K Yamaguchi; K Yamaguchi; T Kato; Y Sugai
Journal:  Neuroradiology       Date:  2001-04       Impact factor: 2.804

6.  Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.

Authors:  T Berger; S Weerth; K Kojima; C Linington; H Wekerle; H Lassmann
Journal:  Lab Invest       Date:  1997-03       Impact factor: 5.662

Review 7.  Spectrum and classification of inflammatory demyelinating diseases of the central nervous system.

Authors:  B Kalman; F D Lublin
Journal:  Curr Neurol Neurosci Rep       Date:  2001-05       Impact factor: 5.081

8.  Multiple sclerosis presenting as isolated oculomotor nerve palsy.

Authors:  R J Uitti; A H Rajput
Journal:  Can J Neurol Sci       Date:  1986-08       Impact factor: 2.104

Review 9.  The peripheral nervous system in multiple sclerosis. A review and pathogenetic hypothesis.

Authors:  C M Poser
Journal:  J Neurol Sci       Date:  1987-06       Impact factor: 3.181

10.  Ophthalmoplegic migraine: reversible enhancement and thickening of the cisternal segment of the oculomotor nerve on contrast-enhanced MR images.

Authors:  A S Mark; J Casselman; D Brown; J Sanchez; M Kolsky; T C Larsen; P Lavin; B Ferraraccio
Journal:  AJNR Am J Neuroradiol       Date:  1998 Nov-Dec       Impact factor: 3.825

View more
  2 in total

1.  Magnetic resonance imaging of the cranial nerves in infectious, neoplastic, and demyelinating diseases, as well as other inflammatory diseases: a pictorial essay.

Authors:  Mariana Dalaqua; Felipe Barjud Pereira do Nascimento; Larissa Kaori Miura; Marcio Ricardo Taveira Garcia; Alcino Alves Barbosa Junior; Fabiano Reis
Journal:  Radiol Bras       Date:  2022 Jan-Feb

2.  Cranial Nerve Enhancement in Multiple Sclerosis Is Associated With Younger Age at Onset and More Severe Disease.

Authors:  Lukas Haider; Wei-Shin Evelyn Chan; Elisabeth Olbert; Stephanie Mangesius; Assunta Dal-Bianco; Fritz Leutmezer; Daniela Prayer; Majda Thurnher
Journal:  Front Neurol       Date:  2019-11-06       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.